Latest Compliance News

29Metals Limited has reversed a significant loss to report a $35.3 million net profit for the first half of 2025, driven by stronger production at Golden Grove and improved metal prices, while Capricorn Copper remains suspended amid ongoing water and regulatory challenges.

Holista Colltech has inked a binding supply and development agreement with US-based Regenerex Pharma to exclusively supply proprietary ovine collagen for advanced wound care products, targeting the lucrative US market initially with plans for global expansion.

Acusensus Limited reported a robust FY25 with 20% revenue growth and a significant 84% jump in total contract value, setting the stage for an ambitious FY26 forecast of up to 41% revenue increase.

Acusensus Limited reported a 20% increase in revenue to $59.35 million for FY25, driven by new and expanded contracts across Australia, New Zealand, the US, and the UK. However, net losses widened by 72.3%, reflecting higher operating expenses and ongoing litigation costs.

AUB Group Limited has reported a robust FY25 financial performance, highlighted by a 171% increase in underlying net profit after tax and a 15.2% rise in total dividends. Strategic acquisitions and organic growth across divisions underpin the company’s strong momentum.

Platinum Asia Investments Limited reported a robust 226% increase in net profit for FY2025, alongside a strategic Scheme of Arrangement to restructure and delist the company from the ASX.

Felix Group Holdings Ltd has announced a $1 million share purchase plan, offering eligible shareholders the chance to buy shares at $0.21 each starting 26 August 2025.

Platinum Asia Investments Limited has refined the payout figure for its final special dividend, enhancing precision for shareholders ahead of the September payment date.

Asset Vision reported robust FY25 results with significant revenue and cash flow growth, achieving a debt-free status while advancing its AI-powered asset management platform.

Polynovo Limited reported a robust 23.3% increase in total revenue for FY25, driven by strong commercial sales growth across the US and international markets. The company is advancing its FDA PMA submission and expanding its global footprint amid strategic product development.

Cyclone Metals Limited's shares have been suspended from trading on the ASX due to a non-compliant announcement, leaving investors in limbo until a suitable update is provided.

Ambertech Limited reported a 6% increase in revenue to $101.2 million for FY25, yet net profit after tax fell sharply by 38% to $0.84 million amid inflationary pressures and increased costs. The company declared a fully franked final dividend and remains optimistic about FY26.